LENSAR, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
LENSAR, INC. (LNSR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $347.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $347.00K, a 54.70% decline year-over-year.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $690.00K, a 5.50% increase year-over-year.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $850.00K, a 27.25% increase year-over-year.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $766.00K, a 12.15% increase year-over-year.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.14M, a 17.94% increase from fiscal 2024.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $2.67M, a 51.89% decline from fiscal 2023.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.54M, a 16.22% decline from fiscal 2022.
- LENSAR, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $6.61M, a 4.31% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $347.00K 10-Q · filed 2026-08-13 | $1.04M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $690.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $3.14M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $850.00K 10-Q · filed 2025-11-06 | $1.62M derived: sum of 2 quarters · filed 2026-08-13 | $2.27M derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-06-30 | $766.00K 10-Q · filed 2026-08-13 | $1.42M derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $654.00K 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $2.67M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $668.00K 10-Q · filed 2025-11-06 | $1.35M derived: sum of 2 quarters · filed 2025-11-06 | $2.00M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $683.00K 10-Q · filed 2025-11-06 | $1.33M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $652.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $5.54M 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $1.17M 10-Q · filed 2024-11-07 | $3.00M derived: sum of 2 quarters · filed 2024-11-07 | $4.72M derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.82M 10-Q · filed 2024-11-07 | $3.55M derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $1.73M 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $6.61M 10-K · filed 2024-03-04 | |||
| 2022-09-30 | $1.67M 10-Q · filed 2023-11-09 | $3.31M derived: sum of 2 quarters · filed 2023-11-09 | $4.92M derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $1.64M 10-Q · filed 2023-11-09 | $3.24M derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $1.61M 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $6.91M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $1.57M 10-Q · filed 2022-11-09 | $3.06M derived: sum of 2 quarters · filed 2022-11-09 | $5.37M derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $1.49M 10-Q · filed 2022-11-09 | $3.79M derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $2.30M 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $8.85M 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $3.86M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |